Literature DB >> 6459357

Combination bronchodilator therapy in asthma.

R E Ruffin, E McIntyre, A J Crockett, K Zielonka, J H Alpers.   

Abstract

This study has compared the short-term bronchodilator effects of inhaled anticholinergic (ipratropium bromide) and sympathomimetic (fenoterol) agents alone and in combination in 18 asthmatic patients. the study was of double-blind, placebo-controlled, crossover design. The combination of 60 micrograms ipratropium bromide and 200 micrograms of fenoterol had a greater bronchodilator effect than lower dose combinations or either drug alone. Small but significant gains may be made with combination inhaled bronchodilator therapy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6459357     DOI: 10.1016/0091-6749(82)90089-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  4 in total

Review 1.  Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing.

Authors:  D M Newnham
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  The role of anticholinergic bronchodilators in adult asthma and chronic obstructive pulmonary disease.

Authors:  K R Chapman
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 3.  Anticholinergic agents for chronic asthma in adults.

Authors:  M Westby; M Benson; P Gibson
Journal:  Cochrane Database Syst Rev       Date:  2004

4.  Comparison of the bronchodilator activities of oxitropium bromide, fenoterol, and their combination in patients with chronic obstructive pulmonary disease and bronchial asthma.

Authors:  K Nishi; M Fujimura; S Myou; T Ooka; S Sakamoto; M Saitou; K Kasahara; T Matsuda
Journal:  Clin Auton Res       Date:  1993-02       Impact factor: 4.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.